Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|October 31, 2003
Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infectionSaurabh Mehandru, Martin MarkowitzCurrent HIV/AIDS Reports|March 15, 2012
Should we treat acute HIV infection?Meagan O'Brien, Martin MarkowitzThe AIDS Reader|August 29, 2006
Predictors of response to highly active antiretroviral therapyAndrea Low, Martin MarkowitzCurrent Opinion in Investigational Drugs (London, England : 2000)|September 8, 2006
Transmitted multidrug resistant HIV-1: new and investigational therapeutic approachesAnita Shet, Martin MarkowitzCurrent Opinion in HIV and AIDS|February 21, 2015
Monoclonal antibodies to host cellular receptors for the treatment and prevention of HIV-1 infectionCraig Pace, Martin MarkowitzAntiviral Research|June 22, 2002
Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspectiveMichael Louie, Martin MarkowitzJournal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
In vitro characterization of multidrug-resistant HIV-1 isolates from a recently infected patient associated with dual tropism and rapid disease progressionHiroshi Mohri, Martin MarkowitzExpert Opinion on Investigational Drugs|August 17, 2010
Novel integrase inhibitors for HIVNicole Prada, Martin MarkowitzCurrent Opinion in HIV and AIDS|October 29, 2019
Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1Martin Markowitz, Jay A GroblerDrugs|February 16, 2013
Next-generation integrase inhibitors : where to after raltegravir?Sharon L Karmon, Martin MarkowitzPageof 12